Associated Papers
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Scollon S et al.
Jco Precision Oncology, 2025
41166674 (PubMed )
Supplement: po-9-e2500742-s001.pdf
MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation.
Kunc M et al.
Contemporary Oncology (poznan, Poland), 2019
Select a paper to view details